Læknablaðið - 15.10.1999, Side 27

LÆKNABLAÐIÐ 1999; 85
791
Table IV. Observed (Obs) and expected (Exp) numbers of cancers, standardised incidence ratio (SIR) and 95% confidence intervals
among 7,904 female factory workers, 20 years of age or older (person-years 75,734) follow-up time 1975-1997. Ten years lag-time
applied.
All cancers (ICD code, 7th revision) Obs no of cancers Exp no of cancers SIR Lower Upper
All cancers (140-205) 513 441.54 1.16 1.06 1.27
Stomach (151) 14 20.70 0.68 0.37 1.13
Colon (153) 36 27.74 1.30 0.91 1.80
Rectum (154) 7 9.06 0.77 0.31 1.59
Pancreas (157) 11 12.57 0.88 0.44 1.57
Lung(162) 67 49.25 1.36 1.05 1.73
Breast (170) 139 116.95 1.19 1.00 1.40
Cervix (171) 20 14.08 1.42 0.87 2.19
Corpus uteri (172) 39 23.07 1.69 1.20 2.31
Ovary (175) 24 29.67 0.81 0.52 1.20
Kidney (180) 13 15.33 0.85 0.45 1.45
Bladder(181) 11 8.62 1.28 0.64 2.28
Mal melanoma of skin (190) 9 11.26 0.80 0.36 1.52
Skin (191) 9 8.76 1.03 0.47 1.95
Brain (193) 24 16.54 1.45 0.93 2.16
Thyroid (194) 20 15.25 1.31 0.80 2.03
Connective tissue (197) 6 2.37 2.53 0.92 5.51
Non spec (199) 10 12.84 0.78 0.37 1.43
Lymphosarcoma (200) 12 8.26 1.45 0.75 2.54
Hogkin's disease (201) 2 1.20 1.67 0.19 6.02
Other lymphomas (202) 0 0.14 - - -
Multiple myeloma (203) 5 4.60 1.09 0.35 2.54
Leukemia (204) 13 8.81 1.48 0.78 2.52
All other cancers 25 26.52 0.94 0.61 1.39
Table V. Observed (Obs) and expected (Exp) numbers of cancers, standardised incidence ratio (SIR) and 95% confidence intervals
among 5,593 female factory workers, 20 years of age or older (person-years 56,203.5), follow-up time 1975-1997. Employment-time
more than lOyears. Ten years lag-time applied.
All cancers (ICD code, 7th revision) Obs. no of cancers Exp. no of cancers SIR Lower Upper
AII cancers (140-205) 397 333.62 1.19 1.08 1.31
Stomach (151) 12 15.89 0.76 0.39 1.32
Colon (153) 28 21.49 1.30 0.87 1.88
Rectum (154) 3 7.05 0.43 0.09 1.24
Pancreas (157) 8 9.77 0.82 0.35 1.61
Lung (162) 48 37.53 1.28 0.94 1.70
Breast (170) 105 86.83 1.21 0.99 1.46
Cervix (171) 13 10.34 1.26 0.67 2.15
Corpus uteri (172) 31 17.34 1.79 1.21 2.54
Ovary (175) 18 22.20 0.81 0.48 1.28
Kidney (180) 9 11.68 0.77 0.35 1.46
Bladder(181) 10 6.72 1.49 0.71 2.74
Mal melanoma of skin (190) 8 8.34 0.96 0.41 1.89
Skin (191) 8 6.73 1.19 0.51 2.34
Brain (193) 18 12.37 1.46 0.86 2.30
Thyroid (194) 14 11.26 1.24 0.68 2.09
Connective tissue (197) 4 1.78 2.25 0.60 5.75
Non spec (199) 7 9.77 0.72 0.29 1.48
Lymphosarcoma (200) 10 6.23 1.61 0.77 2.95
Hogkin’s disease (201) 2 0.90 2.22 0.25 8.02
Other lymphomas (202) 0 0.10 - - -
Multiple myeloma (203) 5 3.56 1.40 0.45 3.28
Leukemia (204) 8 4.78 1.67 0.72 3.30
All other cancers 28 20.96 1.34 0.89 1.93
húsgagna- og byggingariðnaði, steinsteypuiðn-
aði, listiðnaði og leirmunagerð, veiðarfæraiðn-
aði og ýmsum öðrum iðnaði sem fellur undir
starfssvið félaga iðnverkafólks (22). Hlutfall
kvenna af Iðjufélögum hefur yfirleitt verið um
80%, að því leyti er Iðja verkakvennafélag
(23). Samkvæmt upplýsingum frá Hagstofu Is-
lands unnu um 19% starfandi kvenna við iðnað